Jing Kang Shen
Directeur/Membre du Conseil chez SHANGHAI JUNSHI BIOSCIENCES CO., LTD.
Postes actifs de Jing Kang Shen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SHANGHAI JUNSHI BIOSCIENCES CO., LTD. | Directeur/Membre du Conseil | 21/06/2024 | - |
| Independent Dir/Board Member | 21/06/2024 | - | |
| Shanghai Institute of Materia Medica Chinese Academy of Sci | Corporate Officer/Principal | 22/03/2010 | - |
| Directeur/Membre du Conseil | 22/03/2010 | 16/03/2011 | |
| Soochow University | Corporate Officer/Principal | 22/03/2010 | - |
| Fudan University | Corporate Officer/Principal | 22/03/2010 | - |
| Shanghai Association of Pharmacy | Corporate Officer/Principal | 22/03/2010 | - |
MabPlex International Co., Ltd.
 MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China. | Directeur/Membre du Conseil | 01/01/2022 | - |
| Independent Dir/Board Member | 01/01/2022 | - | |
| Yantai Mabplex International Biomedical Co. Ltd. | Directeur/Membre du Conseil | 01/09/2018 | - |
| Independent Dir/Board Member | 01/09/2018 | - |
Historique de carrière de Jing Kang Shen
Anciens postes connus de Jing Kang Shen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ZHEJIANG JINGXIN PHARMACEUTICAL CO., LTD. | Directeur/Membre du Conseil | 22/03/2010 | 17/03/2011 |
| Independent Dir/Board Member | 17/03/2011 | - |
Formation de Jing Kang Shen
| Kyoto University | Doctorate Degree |
Statistiques
Internationale
| Chine | 9 |
| Japon | 2 |
Opérationnelle
| Director/Board Member | 5 |
| Independent Dir/Board Member | 4 |
| Corporate Officer/Principal | 4 |
Sectorielle
| Consumer Services | 5 |
| Health Technology | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ZHEJIANG JINGXIN PHARMACEUTICAL CO., LTD. | Health Technology |
| SHANGHAI JUNSHI BIOSCIENCES CO., LTD. | Health Technology |
| Entreprise privées | 3 |
|---|---|
| Shanghai Association of Pharmacy | |
MabPlex International Co., Ltd.
MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China. | Health Technology |
| Yantai Mabplex International Biomedical Co. Ltd. |
- Bourse
- Insiders
- Jing Kang Shen
- Expérience
